A research team from the University of Alberta report a new approach to treating breast and thyroid cancer by targeting an enzyme that is responsible for the "vicious cycle" of tumour growth, spread and resistance to treatment. A team, led by University of Alberta biochemistry professor David Brindley, found that inhibiting the activity of an enzyme called autotaxin, decreases early tumour growth in the breast by up to 70 per cent. It also cuts the spread of the ...
via Medindia Health News
More READ
No comments:
Post a Comment